Insights from Wafik S. El-Deiry from Bioengineering and Cancer retreat

Wafik S. El-Deiry shared a post on LinkedIn:

“Robert W. Sobol Jr. speaks about DNA damage and repair pathway in cancer at the Bioengineering and Cancer retreat today. Very cool innovative DNA repair assays, TurboID technology and LivePAR imaging in understanding repair, resistance mechanisms and effects of novel therapeutics. Exciting capabilities at our institution for cellular and molecular imaging relevant to cancer and its therapy.

Anubhav Tripathi at Brown University School of Engineering speaks at the Cancer and Bioengineering Symposium at Brown University The Warren Alpert Medical School of Brown University about an array of technology platforms for accelerating diagnostics, biotherapeutics, and clinical translation.

Great talk by Brown University predoctoral student Zixi Lin on two-photon microscopy and translational applications. Comparisons of benign and malignant tissue, collagen, and clinical correlations in rectal cancer and breast cancer were discussed.”

Source: Wafik S. El-Deiry/LinkedIn

Wafik El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget.

Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.